Overview
What is Scleroderma Clinical Trials Consortium Inc?
Scleroderma Clinical Trials Consortium Inc, located in Boston, Massachusetts, is a nonprofit organization dedicated to accelerating medical research in the field of scleroderma. Their primary mission is to foster scientific studies and advance treatment trials globally for this condition. By conducting these trials, they aim to improve and expand the available treatment options for patients worldwide. The consortium's activities are focused on promoting medical research in the context of scleroderma, with the ultimate goal of enhancing patient outcomes and quality of life.
Official website here: www.sctconline.org
Is Scleroderma Clinical Trials Consortium Inc legitimate?
Scleroderma Clinical Trials Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Scleroderma Clinical Trials Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.sctconline.org
What is the mission statement of Scleroderma Clinical Trials Consortium Inc?
The Scleroderma Clinical Trials Consortium Inc is committed to fostering scientific research and advancing medical progress in the field of scleroderma treatment trials on a global scale. Their mission is to promote the conduct of clinical trials aimed at discovering effective treatments for scleroderma, a chronic autoimmune disease. By facilitating these trials worldwide, they aim to accelerate the development of new therapies and improve the lives of those affected by scleroderma. Their activities focus on bringing together researchers, healthcare providers, and patients to collaborate on innovative studies and share scientific findings.
Official website here: www.sctconline.org
Who is the CEO of Scleroderma Clinical Trials Consortium Inc?
Jerry Molitor is the President of Scleroderma Clinical Trials Consortium Inc.
Official website here: www.sctconline.org
What is the revenue of Scleroderma Clinical Trials Consortium Inc?
Scleroderma Clinical Trials Consortium Inc's revenue in 2022 was $271,981.
Official website here: www.sctconline.org
Who are the executives of Scleroderma Clinical Trials Consortium Inc and what are their salaries?
Here are 4 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.sctconline.org
Where can I find the form 990 for Scleroderma Clinical Trials Consortium Inc?
Scleroderma Clinical Trials Consortium Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.sctconline.org
Learn more at the official website: www.sctconline.org
Mission Statement of Scleroderma Clinical Trials Consortium Inc
The Scleroderma Clinical Trials Consortium Inc is committed to fostering scientific research and advancing medical progress in the realm of treatment trials for scleroderma on a global scale. Their mission is to push the boundaries of medical knowledge in this specific disease, aiming to develop novel therapies and improve the overall outlook for scleroderma patients worldwide. By driving research efforts and facilitating treatment trials, this organization strives to make significant strides in the fight against scleroderma, ultimately benefiting individuals and families affected by this complex condition.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Scleroderma Clinical Trials Consortium Inc significantly impacts the landscape of medical research and treatment for scleroderma, a complex autoimmune disease. By fostering scientific research and advancing medical trials globally, the Consortium plays a crucial role in enhancing the understanding of scleroderma and developing effective therapies.
Their effort to facilitate treatment trials creates opportunities for innovative treatments to be tested, which can lead to breakthroughs in managing and potentially curing the disease. The Consortium connects researchers, clinicians, and patients, ensuring a collaborative approach that enriches the research community's knowledge and resources.
Through its commitment to rigorous scientific inquiry, the Consortium also helps raise awareness of scleroderma among stakeholders, including healthcare providers and policymakers. This can lead to increased funding and support for further research initiatives, ultimately benefiting patients who suffer from this challenging condition. Overall, the work of the Scleroderma Clinical Trials Consortium Inc is vital in translating scientific discoveries into real-world treatments, paving the way for improved health outcomes in scleroderma patients worldwide.
This information is meant to be a general summary of Scleroderma Clinical Trials Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $83,666
- Gross Receipts: $271,981
Assets and Liabilities:
- Total Assets: $2,536,410
- Total Liabilities: $0
- Net Assets: $2,536,410
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2001
Phone
(801) 548-4837Principal Officer
Jerry Molitor
Main Address
BU SCH MEDICINE 718 ALBANY ST E-5, BOSTON, MA, 02118
Website
www.sctconline.orgNTEE Category
Code: H99 - Medical research
If you are a representative of Scleroderma Clinical Trials Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.